Retinoblastoma protein regulation by the COP9 signalosome

Zakir Ullah1, Martin S Buckley, David N Arnosti

  • 1Department of Biochemistry and Molecular Biology and Genetics Program, Michigan State University, East Lansing, MI 48824, USA.

Insights

The COP9 signalosome (CSN) interacts with Drosophila Rbf proteins, protecting them from proteasomal degradation. This interaction is crucial for regulating cell cycle and gene expression during development.

Area of Science:

  • Molecular Biology
  • Developmental Biology
  • Cell Biology

Background:

  • Drosophila Rbf1 and Rbf2 proteins regulate cell cycle and gene expression, similar to human Retinoblastoma proteins.
  • Rbf proteins are thought to function within multiprotein complexes to control gene transcription.

Purpose of the Study:

  • To investigate the interaction between the COP9 signalosome (CSN) and Rbf proteins in Drosophila.
  • To determine the role of CSN in Rbf protein stability and transcriptional regulation during development.

Main Methods:

  • Co-immunoprecipitation to detect physical interactions between CSN and Rbf2.
  • Chromatin immunoprecipitation to identify CSN4 subunit occupancy at Rbf target gene promoters.
  • RNA interference (RNAi) to knock down CSN subunits and assess Rbf protein levels and cell cycle progression.
  • Proteasome activity assays to evaluate Rbf protein degradation.

Main Results:

  • The developmentally regulated COP9 signalosome (CSN) physically interacts with Rbf2 during Drosophila embryogenesis.
  • The CSN4 subunit co-localizes with Rbf1 and Rbf2 at their target gene promoters, indicating a role in transcriptional regulation.
  • Knockdown of CSN subunits reduces Rbf1 and Rbf2 protein levels and disrupts cell cycle progression.
  • Diminished COP9 activity increases proteasome-mediated degradation of Rbf1 and Rbf2, suggesting CSN protects these proteins.

Conclusions:

  • The COP9 signalosome (CSN) plays a protective role for Rbf proteins (Rbf1 and Rbf2) during Drosophila embryogenesis.
  • CSN likely stabilizes Rbf proteins by inhibiting their proteasomal degradation, thereby enabling proper retinoblastoma gene control.
  • This study suggests a novel mechanism where promoter-associated CSN and the proteasome regulate Rbf protein lifespan and developmental gene expression.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...